The Changing Economics of Medical Technology


Book Description

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.







The Changing Economics of Medical Technology


Book Description

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.




The Impact of Information Technology


Book Description

First published in 2000. This book addresses the measurement of the effect of information technology (IT) investments on a firm's productivity. Determining a quantifiable impact of a firm's IT has plagued senior executives, researchers, and policy-makers for several years, as evidenced by articles in trade magazines such as Fortune and Businessweek and in academic journals such as Management Science. Simple statistical techniques for measuring IT impact in a firm are fraught with methodological problems, as these techniques do not account for either the causal direction in managerial decision making or the behavioral assumptions about firms. Therefore, such studies have led to results and inferences that are not generalizable. While studies that measure the satisfaction of people who use IT are important, management typically would like to know whether IT has reduced operation costs by streamlining processes or increased revenues by increasing the demand-meeting capability of the firm. This book attempts to determine cost-reduction or output-enhancement that may be linked to IT investments through methodological sophistication. The healthcare industry presents an important and interesting context in which to study IT impacts for several reasons. First, since the implementation of the Prospective Payment System (PPS) by Medicaid, most hospitals adopted cost containment measures, and hence capital investments in hospitals have come under greater scrutiny than ever before. Second, hospitals have been more thorough in reporting capital and labor expenses and revenues (due to state regulation) at a level of detail that makes it possible to aggregate IT and other capital investments without serious measurement error. Most non-healthcare firms do not collect or report such data in their financial statements. Finally, though hospitals were slow in IT adoption, most hospitals have been acquiring sophisticated hardware and software over the past few years. Results of the analysis bear evidence of the positive impact of IT on production of healthcare services. It also shows how methodological differences can lead to conflicting results. The effect of PPS determined in a comparative way shows that the economic behavior in the post-PPS differs from that in the pre-PPS years.




Health Care and Its Financing in the Single European Market


Book Description

Health care and its financing will not be harmonized within the European Union (EU). Therefore, the differences between the health systems of the member-states in a Single European Market are gaining in relevance. The process of economic integration also effects health. This book integrates economics, law, social, political and health sciences in the analysis of health care issues in the EU. It covers the development of health systems and policy in the community, the markets for pharmaceuticals and for medical devices, EU-trends in hospital financing, issues in the comparison of financing systems, especially in the field of private expenditures, reforms of health care financing in social security systems and national health services in the EU and cross-border health care between EU member-states. The results feature an up-to date overview on the European dimension of health care and its financing. The book is relevant to experts in health care organizations, policy, industry and research.







Technological Change and Economic Performance


Book Description

Reviews of the literature on historical and theoretical developments of technology and economic growth including productivity measures, technical knowledge, technological spillovers and stock market reactions to technology investment.




Modern Methods of Clinical Investigation


Book Description

The very rapid pace of advances in biomedical research promises us a wide range of new drugs, medical devices, and clinical procedures. The extent to which these discoveries will benefit the public, however, depends in large part on the methods we choose for developing and testing them. Modern Methods of Clinical Investigation focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. Essays explore differences in our current systems for evaluating drugs, medical devices, and clinical procedures; health insurance databases as a tool for assessing treatment outcomes; the role of the medical profession, the Food and Drug Administration, and industry in stimulating the use of evaluative methods; and more. This book will be of special interest to policymakers, regulators, executives in the medical industry, clinical researchers, and physicians.




Drug Benefits and Risks


Book Description

This is an inclusive reference exploring the scientific basis and practice of drug therapy. The key concept is to look at the balance between the benefits and risks of drugs but in this context also the social impact which drugs have in modern societies is highlighted. Taking an evidence-based approach to the problem, the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world is examined. For this purpose the book * Covers general clinical pharmacology, pharmacology of various drug groups and the treatments specific to various diseases * Gives guidance on how doctors should act so that drugs can be used effectively and safely * Encourages the rational use of drugs in society This book brings together a large amount of excellent content that will be invaluable for anyone working within, or associated with, the field of clinical pharmacology and pharmacotherapy - undergraduates, postgraduates, regulatory authorities and the pharmaceutical industry.